ICU patients are at high risk for venous thromboembolism, and the majority of patients require prophylaxis. The challenging therapy is thrombocytopenia. Join host Geoff Wall, as he evaluates the results of a new study evaluating the clinical thresholds for chemical prophylaxis.

The GameChanger
The majority of ICU patients eligible for VTE prophylaxis do not receive it. Different clinicians use different thresholds to initiate or stop prophylaxis. The database study discussed provides a potential evidence-based threshold.

Show Segments
00:00 - Introductions
00:47 - VTE Prophylaxis Background
09:34 - Looking at the Study
18:42 - The GameChanger: A Potential Threshold for Chemical Prophylaxis
22:15 - Connecting to Practice: Applicability
26:13 - Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

References and Resources
Association between Early Venous Thromboembolism Prophylaxis, Bleeding Risk, and Venous Thromboembolism among Critically Ill Patients with Thrombocytopenia.

Redeem your CPE here
CPE (Pharmacist)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
Pharmacists: Get a membership

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the history and use of VTE prophylaxis in the ICU
2. Describe the results of the Pang et al study discussed and its applicability to ICU patients

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-134-H01-P
Initial release date: 04/10/2023
Expiration date: 04/10/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram